IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer.
Saved in:
| Title: | IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer. |
|---|---|
| Authors: | Hur J; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Fantini M; Precision Biologics, Inc., Bethesda, MD, United States., Hernandez L; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Korrapati S; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Edmondson EF; Molecular Histopathology Laboratory, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Cam M; Center for Cancer Research Collaborative Bioinformatics Resource (CCBR), National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Tandon M; Center for Cancer Research Collaborative Bioinformatics Resource (CCBR), National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Cole CB; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Tsang KY; Precision Biologics, Inc., Bethesda, MD, United States., Arlen PM; Precision Biologics, Inc., Bethesda, MD, United States., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Morelli MP; Department of Gastrointestinal Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 24; Vol. 17, pp. 1652596. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1652596 |
